DIG
IBIO icon

Dauntless Investment Group’s iBio IBIO Stock Holding History

Dauntless Investment Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,000
Closed -$15.2K – 85
2025
Q2 		$15.2K Buy
+20,000
New +$21.7K 0.03% 63

Other funds holding IBIO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Dauntless Investment Group's IBIO Position: Q3 2025 in Review

Dauntless Investment Group sold out of iBio (IBIO) in Q3 2025, closing a stake of 20,000 shares — an estimated $15.2K sold.

Dauntless Investment Group first reported a position in IBIO in Q2 2025 and held it in 1 quarter. The position peaked at $15.2K in Q2 2025. 32 funds tracked by Wall St. Rank hold IBIO as of Q3 2025.

  • Dauntless Investment Group reported no remaining iBio position as of Q3 2025 after selling out during the quarter.
  • Dauntless Investment Group sold 20,000 iBio shares in Q3 2025, an estimated $15.2K.
  • Dauntless Investment Group first reported a position in iBio in Q2 2025 and held it in 1 quarter.
  • Dauntless Investment Group's iBio position peaked at $15.2K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held iBio as of Q3 2025.

Based on Dauntless Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.